|
|
|
|
LEADER |
00000cam a2200000 i 4500 |
001 |
SCIDIR_on1082875314 |
003 |
OCoLC |
005 |
20231120010337.0 |
006 |
m o d |
007 |
cr ||||||||||| |
008 |
190118t20192019enka ob 001 0 eng d |
040 |
|
|
|a YDX
|b eng
|e rda
|e pn
|c YDX
|d N$T
|d EBLCP
|d N$T
|d OPELS
|d OCLCF
|d MMU
|d OCLCO
|d TMC
|d CASUM
|d OCLCO
|d TMC
|d STF
|d OCLCO
|d OPELS
|d OCLCQ
|d OCLCA
|d OCLCQ
|d S2H
|d OCLCO
|d LVT
|d VT2
|d OCLCQ
|d OPELS
|d OCLCO
|d OCLCQ
|d OCLCO
|
015 |
|
|
|a GBB918868
|2 bnb
|
019 |
|
|
|a 1082356344
|a 1082965219
|a 1229474262
|a 1235827532
|a 1311344075
|a 1311348739
|
020 |
|
|
|a 9780128120040
|q (electronic bk.)
|
020 |
|
|
|a 0128120045
|q (electronic bk.)
|
020 |
|
|
|z 9780128120057
|q (paperback)
|
020 |
|
|
|z 0128120053
|q (paperback)
|
035 |
|
|
|a (OCoLC)1082875314
|z (OCoLC)1082356344
|z (OCoLC)1082965219
|z (OCoLC)1229474262
|z (OCoLC)1235827532
|z (OCoLC)1311344075
|z (OCoLC)1311348739
|
050 |
|
4 |
|a RC280.N4
|
060 |
|
4 |
|a QZ 380
|
072 |
|
7 |
|a HEA
|x 039000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 022000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 112000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 045000
|2 bisacsh
|
082 |
0 |
4 |
|a 616.99383
|2 23
|
245 |
0 |
0 |
|a Neuroblastoma :
|b molecular mechanisms and therapeutic interventions /
|c edited by Swapan K. Ray.
|
264 |
|
1 |
|a London :
|b Academic Press, an imprint of Elsevier,
|c [2019]
|
264 |
|
4 |
|c �2019
|
300 |
|
|
|a 1 online resource (x, 323 pages) :
|b illustrations (some color)
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
504 |
|
|
|a Includes bibliographical references and index.
|
505 |
0 |
|
|a Neuroblastoma pathology and classification -- Role of genetic and epigenetic alterations in pathogenesis of neuroblastoma -- Neuroblastoma molecular biology and promising therapeutic targets -- The GD2-targeted immunotherapy of neuroblastoma -- Targeting angiogenesis in neuroblastoma -- Autophagy and novel therapeutic strategies in neuroblastoma -- Energy metabolism and new therapeutic opportunities in neuroblastoma -- Multimodality imaging for diagnosis of neuroblastoma -- Immunotherapy for neuroblastoma -- Advances in surgical treatment of neuroblastoma -- Role of stemness factors in neuroblastoma: Neuroblastoma stem cells, tumor microenvironment, and chemoresistance -- Current pharmacotherapy for neuroblastoma -- Current challenges in the management of neuroblastoma -- Novel therapeutic targets in neuroblastoma -- Current and future strategies for treatment of relapsed neuroblastoma -- Current evidence in favor of a tumor suppressor role of Kr�uppel-like factor 4 in malignant neuroblastoma -- Modulation of expression of microRNA as a therapeutic strategy in malignant neuroblastoma.
|
520 |
|
|
|a "Neuroblastoma: Molecular Mechanisms and Therapeutic Interventions comprehensively reviews current concepts in molecular and histopathological mechanisms that influence the growth of human malignant neuroblastoma, along with exciting therapeutic interventions. This book features a broad collection of contributions from leading investigators in histopathology, molecular mechanisms, genetics, epigenetics, microRNAs, proteomics, and metabolism in controlling growth and death in neuroblastoma. Recent developments in therapeutic interventions for neuroblastoma are also covered extensively, including chapters on surgery, chemotherapy, targeted therapy and immunotherapy. This book is ideal for advanced undergraduate students, graduate students, medical students, postdoctoral fellows, and investigators with an interest in current molecular concepts and therapeutic interventions"--Publisher's description
|
588 |
0 |
|
|a Online resource; title from resource home page (ClinicalKey, viewed March 14, 2019).
|
650 |
|
0 |
|a Neuroblastoma.
|
650 |
|
0 |
|a Neuroblastoma
|x Treatment.
|
650 |
1 |
2 |
|a Neuroblastoma
|0 (DNLM)D009447
|
650 |
|
6 |
|a Neuroblastome.
|0 (CaQQLa)201-0057517
|
650 |
|
6 |
|a Neuroblastome
|0 (CaQQLa)201-0057517
|x Traitement.
|0 (CaQQLa)201-0377521
|
650 |
|
7 |
|a HEALTH & FITNESS
|x Diseases
|x General.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Clinical Medicine.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Diseases.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Evidence-Based Medicine.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Internal Medicine.
|2 bisacsh
|
650 |
|
7 |
|a Neuroblastoma
|2 fast
|0 (OCoLC)fst01036325
|
655 |
|
4 |
|a Computer network resources.
|
655 |
|
4 |
|a Fulltext.
|
655 |
|
4 |
|a Internet Resources.
|
700 |
1 |
|
|a Ray, Swapan K.,
|e editor.
|
776 |
0 |
8 |
|i Print version:
|t Neuroblastoma.
|d London : Academic Press, an imprint of Elsevier, [2019]
|z 9780128120057
|w (OCoLC)1041882371
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780128120057
|z Texto completo
|